ID

30423

Beschrijving

SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715); ODM derived from: https://clinicaltrials.gov/show/NCT00871546

Link

https://clinicaltrials.gov/show/NCT00871546

Trefwoorden

Versies (1)
  1. 04-06-18 04-06-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

4 juni 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Lymphoma, Mantle-Cell NCT00871546

Engels

Eligibility Lymphoma, Mantle-Cell NCT00871546

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
age >=18 years, either sex, any race.
Beschrijving

Age | Race Any

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0034510
UMLS CUI [2,2]
C1552551
eastern cooperative oncology group performance status of 0 or 1.
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
adequate hematologic, renal, and hepatic organ function and laboratory parameters.
Beschrijving

Hematologic function | Renal function | Liver function | Laboratory Results

Datatype

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
UMLS CUI [4]
C1254595
for subjects with mcl:
Beschrijving

Study Subject Mantle cell lymphoma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0334634
diagnosis of mcl according to the world health organization (who) criteria.
Beschrijving

Mantle cell lymphoma WHO tumor classification

Datatype

boolean

Alias
UMLS CUI [1,1]
C0334634
UMLS CUI [1,2]
C1301142
received at least one prior chemotherapeutic regimen, but no more than two regimens including stem cell transplantation..
Beschrijving

Chemotherapy Regimen Quantity | Stem cell transplant

Datatype

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [2]
C1504389
measurable or assessable disease by the revised response criteria for malignant lymphoma.
Beschrijving

Measurable Disease | Evaluable Disease

Datatype

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
for subjects with b-cll
Beschrijving

Study Subject Chronic Lymphocytic Leukemia

Datatype

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0023434
documented b-cll according to the national cancer institute working group (nci-wg) criteria.
Beschrijving

Chronic Lymphocytic Leukemia

Datatype

boolean

Alias
UMLS CUI [1]
C0023434
received at least one prior alkylating agent-based regimen and one fludarabine-
Beschrijving

Alkylating Agents | fludarabine | Therapeutic procedure Quantity

Datatype

boolean

Alias
UMLS CUI [1]
C0002073
UMLS CUI [2]
C0059985
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C1265611
or pentostatin-containing regimen, but must not have received more than two prior regimens.
Beschrijving

Pentostatin | Prior Therapy Quantity

Datatype

boolean

Alias
UMLS CUI [1]
C0030896
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C1265611
measurable or assessable disease by nci-wg criteria.
Beschrijving

Measurable Disease | Evaluable Disease

Datatype

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
known central nervous system involvement of mcl or b-cll.
Beschrijving

Central Nervous System Involvement Mantle cell lymphoma | Central Nervous System Involvement Chronic Lymphocytic Leukemia

Datatype

boolean

Alias
UMLS CUI [1,1]
C4050309
UMLS CUI [1,2]
C0334634
UMLS CUI [2,1]
C4050309
UMLS CUI [2,2]
C0023434
previous treatment with sch 727965 or other cyclin-dependent kinase inhibitors.
Beschrijving

SCH 727965 | Cyclin-Dependent Kinase Inhibitors

Datatype

boolean

Alias
UMLS CUI [1]
C2711996
UMLS CUI [2]
C1511576
for mcl, previous treatment with bortezomib.
Beschrijving

Bortezomib | Study Subject Mantle cell lymphoma

Datatype

boolean

Alias
UMLS CUI [1]
C1176309
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0334634
for b-cll, previous treatment with alemtuzumab.
Beschrijving

Alemtuzumab | Study Subject Chronic Lymphocytic Leukemia

Datatype

boolean

Alias
UMLS CUI [1]
C0383429
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0023434
known hiv infection.
Beschrijving

HIV Infection

Datatype

boolean

Alias
UMLS CUI [1]
C0019693
known active hepatitis b or c.
Beschrijving

Hepatitis B | Hepatitis C

Datatype

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
Terug naar het begin van de pagina

Similar models

Eligibility Lymphoma, Mantle-Cell NCT00871546

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age | Race Any
Item
age >=18 years, either sex, any race.
boolean
C0001779 (UMLS CUI [1])
C0034510 (UMLS CUI [2,1])
C1552551 (UMLS CUI [2,2])
ECOG performance status
Item
eastern cooperative oncology group performance status of 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Hematologic function | Renal function | Liver function | Laboratory Results
Item
adequate hematologic, renal, and hepatic organ function and laboratory parameters.
boolean
C0221130 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C1254595 (UMLS CUI [4])
Study Subject Mantle cell lymphoma
Item
for subjects with mcl:
boolean
C0681850 (UMLS CUI [1,1])
C0334634 (UMLS CUI [1,2])
Mantle cell lymphoma WHO tumor classification
Item
diagnosis of mcl according to the world health organization (who) criteria.
boolean
C0334634 (UMLS CUI [1,1])
C1301142 (UMLS CUI [1,2])
Chemotherapy Regimen Quantity | Stem cell transplant
Item
received at least one prior chemotherapeutic regimen, but no more than two regimens including stem cell transplantation..
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1504389 (UMLS CUI [2])
Measurable Disease | Evaluable Disease
Item
measurable or assessable disease by the revised response criteria for malignant lymphoma.
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
Study Subject Chronic Lymphocytic Leukemia
Item
for subjects with b-cll
boolean
C0681850 (UMLS CUI [1,1])
C0023434 (UMLS CUI [1,2])
Chronic Lymphocytic Leukemia
Item
documented b-cll according to the national cancer institute working group (nci-wg) criteria.
boolean
C0023434 (UMLS CUI [1])
Alkylating Agents | fludarabine | Therapeutic procedure Quantity
Item
received at least one prior alkylating agent-based regimen and one fludarabine-
boolean
C0002073 (UMLS CUI [1])
C0059985 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
Pentostatin | Prior Therapy Quantity
Item
or pentostatin-containing regimen, but must not have received more than two prior regimens.
boolean
C0030896 (UMLS CUI [1])
C1514463 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Measurable Disease | Evaluable Disease
Item
measurable or assessable disease by nci-wg criteria.
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Central Nervous System Involvement Mantle cell lymphoma | Central Nervous System Involvement Chronic Lymphocytic Leukemia
Item
known central nervous system involvement of mcl or b-cll.
boolean
C4050309 (UMLS CUI [1,1])
C0334634 (UMLS CUI [1,2])
C4050309 (UMLS CUI [2,1])
C0023434 (UMLS CUI [2,2])
SCH 727965 | Cyclin-Dependent Kinase Inhibitors
Item
previous treatment with sch 727965 or other cyclin-dependent kinase inhibitors.
boolean
C2711996 (UMLS CUI [1])
C1511576 (UMLS CUI [2])
Bortezomib | Study Subject Mantle cell lymphoma
Item
for mcl, previous treatment with bortezomib.
boolean
C1176309 (UMLS CUI [1])
C0681850 (UMLS CUI [2,1])
C0334634 (UMLS CUI [2,2])
Alemtuzumab | Study Subject Chronic Lymphocytic Leukemia
Item
for b-cll, previous treatment with alemtuzumab.
boolean
C0383429 (UMLS CUI [1])
C0681850 (UMLS CUI [2,1])
C0023434 (UMLS CUI [2,2])
HIV Infection
Item
known hiv infection.
boolean
C0019693 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
known active hepatitis b or c.
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial